Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avantor, Inc.

16.30
+0.48003.03%
Post-market: 16.300.00000.00%16:09 EDT
Volume:5.10M
Turnover:82.62M
Market Cap:11.10B
PE:15.67
High:16.35
Open:15.95
Low:15.88
Close:15.82
Loading ...

Company Profile

Company Name:
Avantor, Inc.
Exchange:
NYSE
Establishment Date:
1904
Employees:
13500
Office Location:
Radnor Corporate Center,Building One,Suite 200,100 Matsonford Road,Radnor,Pennsylvania,United States
Zip Code:
19087
Fax:
- -
Introduction:
Avantor, Inc. engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides logistics, chemical and equipment tracking, and glassware autoclaving, as well as scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Directors

Name
Position
Michael Stubblefield
Director, President and Chief Executive Officer
Rajiv L. Gupta
Chairman of the Board
Jonathan Peacock
Lead Independent Director
Christi Shaw
Director
Greg Summe
Director
John Carethers
Director
Joseph Massaro
Director
Juan Andres
Director
Lan Kang
Director
Mala Murthy
Director
Matthew Holt
Director
Michael E. Severino
Director

Shareholders

Name
Position
Michael Stubblefield
Director, President and Chief Executive Officer
Thomas Szlosek
Executive Vice President and Chief Financial Officer
Christophe Couturier
Executive Vice President, AMEA
Frederic Vanderhaegen
Executive Vice President, Americas and Europe
Gerard Brophy
Executive Vice President, Biopharma Production
Justin Miller
Executive Vice President, General Counsel and Secretary
Meghan Henson
Executive Vice President and Chief Human Resources Officer
Sheri Lewis
Executive Vice President, Global Operations and Supply Chain